BioSpace News Archive

MR Solutions has installed the first 7T PET/MR preclinical imaging system in Israel.

Pinpoint Scientific is pleased to announce it has secured further investment into the business, to aid the development of its ImpactAir® range of environmental monitoring solutions.

ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at Evercore ISI 2nd Annual HealthCONx Conference on Wednesday, December 4, 2019

Marketing technology companies join forces to offer an enhanced, complementary service offering to a larger customer base

The Company reported revenue of $234,977 for the three months ended September 30, 2019, compared with revenue of $180,404 for the three months ended September 30, 2018.

First published evidence showing that individual fetal fraction measurement is a critical determinant of test reliability

Chief Executive Officer will participate in an analyst-led fireside chat at the upcoming Piper Jaffray 31st Annual Healthcare Conference taking place December 3 - 5, 2019 in New York, NY.

Aravive expects to receive gross proceeds of approximately $25 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Aravive.

The RSNA 2019 conference and exhibit will take place December 1 - 6, 2019, at McCormick Place in Chicago.

The Multiple Sclerosis (MS) Society of Canada announced today a $1 million donation from TD Bank Group to support research that uses artificial intelligence (AI) to develop clinical tools to enable more informed healthcare decisions in relation to disease-modifying therapies (DMTs) for people with MS.